Merck reported EUR2.28B in Cost of Sales for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Cost Of Sales Change
Adidas ADS:GR EUR 3.17B 92M
Adyen ADYEN:NA EUR 4.27B 927.54M
Akzo Nobel AKZA:NA EUR 1.68B 209M
Alcon AG ALC:SW USD 998M 26M
Amadeus IT AMS:SM EUR 282.6M 27.8M
Amarin AMRN:US USD 23.94M 11.87M
Artemis Alpha ATS:LN GBP 507K 125K
AstraZeneca AZN:LN USD 2.51B 393M
BASF BAS:GR EUR 14.98B 2.08B
Bayer BAYN:GR EUR 4.77B 521M
Covestro 1COV:GR EUR 4.07B 8M
Fresenius FRE:GR EUR 7.86B 105M
Fresenius Medical Care FME:GR EUR 3.65B 88.58M
Givaudan GIVN:VX CHF 2.16B 31M
GlaxoSmithKline GSK:LN GBP 2.18B 209M
Hikma Pharmaceutical HIK:LN USD 662M 72M
Infineon Technologie IFX:GR EUR 2.08B 218M
Linde LIN:GR USD 4.43B 858M
Merck MRK:GR EUR 2.28B 137M
Novartis NOVN:VX USD 3.84B 180M
Philips PHIA:NA EUR 3.2B 621M
Roche Holding ROG:VX 8.95B 613M